DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NOVOSEVEN

« Back to Dashboard

All Clinical Trials for NOVOSEVEN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00104455	Dose Response to Recombinant Factor VIIa When Administered for Bleed	Completed	Novo Nordisk A/S	Phase 1	2004-06-01	This trial is conducted in the United States of America (USA). The purpose of this trial is to investigate the dose response to recombinant factor VIIa in healthy volunteers when administered for bleed.
NCT00108758	Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia	Completed	Novo Nordisk A/S	Phase 2	2004-03-01	This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylactic treatment with NovoSeven® in haemophilia A and B patients with inhibitors.
NCT00108797	Trial of NovoSeven® in Haemophilia - Joint Bleeds	Completed	Novo Nordisk A/S	Phase 4	2001-09-01	This trial is conducted in the United States of America (USA). This study compares the effectiveness and safety of NovoSeven® to FEIBA (FEIBA VH) in haemophilia patients with inhibitors being treated for joint bleeds.

Clinical Trial Conditions for NOVOSEVEN

Condition Name

Condition Name for NOVOSEVEN
Intervention	Trials
Congenital Bleeding Disorder	23
Acquired Bleeding Disorder	20
Haemophilia B With Inhibitors	13

Condition MeSH

Condition MeSH for NOVOSEVEN
Intervention	Trials
Blood Coagulation Disorders	41
Hemostatic Disorders	41
Hemophilia A	24

Clinical Trial Locations for NOVOSEVEN

Trials by Country

Trials by Country for NOVOSEVEN
Location	Trials
United States	122
Germany	18
United Kingdom	16
Italy	16
France	16

Trials by US State

Trials by US State for NOVOSEVEN
Location	Trials
California	9
New Jersey	8
Texas	8
Pennsylvania	7
Ohio	6

Clinical Trial Progress for NOVOSEVEN

Clinical Trial Phase

Clinical Trial Phase for NOVOSEVEN
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	7
Phase 2	18

Clinical Trial Status

Clinical Trial Status for NOVOSEVEN
Clinical Trial Phase	Trials
Completed	43
Terminated	4
Not yet recruiting	2

Clinical Trial Sponsors for NOVOSEVEN

Sponsor Name

Sponsor Name for NOVOSEVEN
Sponsor	Trials
Novo Nordisk A/S	43
National Institute of Neurological Disorders and Stroke (NINDS)	2
Octapharma	1

Sponsor Type

Sponsor Type for NOVOSEVEN
Sponsor	Trials
Industry	44
Other	12
NIH	2